Literature DB >> 30045656

Rapid induction of pancreatic cancer cells to cancer stem cells via heterochromatin modulation.

Zhengyan Xu1, Yanjun Jia1, Xiaoxi Huang1, Nianhua Feng1, Ying Li1.   

Abstract

Mounting evidence supports that CSCs (cancer stem cells) play a vital role in cancer recurrence. Therefore elimination of CSCs is currently considered to be an important therapeutic strategy for complete remission. A major obstacle in CSC research is the obtainment of sufficient numbers of functional CSC populations. Here, we established a method to induce bulk pancreatic cancer cells to CSCs via heterochromatin modulation. Two pancreatic cancer cell lines Panc1 and Bxpc3 were cultured for 4 days in inducing medium (mTeSR containing FBS, B27, MEK inhibitor, GSK3 inhibitor, and VPA), and another 2 days in sphere culture medium (mTeSR supplemented with B27). Then the induced cells were dissociated into single cells and cultured in suspension in sphere culture medium. It was found that the majority of induced cells formed spheres which could grow larger and be passaged serially. Characterization of Panc1 sphere cells demonstrated that the sphere cells expressed increased pancreatic cancer stem cell surface markers and stem cell genes, were more resistant to chemotherapy, and were more tumorigenic in vivo, indicating that the induced sphere cells acquired CSC properties. Thus, the inducing method we developed may be used to obtain a sufficient number of CSCs from cancer cells, and contribute to the research for CSC-targeting therapy.

Entities:  

Keywords:  Pancreatic cancer stem cells; heterochromatin; small molecular compounds

Mesh:

Substances:

Year:  2018        PMID: 30045656      PMCID: PMC6132961          DOI: 10.1080/15384101.2018.1489180

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  31 in total

1.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

Review 2.  The ever-changing landscape of pancreatic cancer stem cells.

Authors:  Patricia Sancho; Sonia Alcala; Valentyn Usachov; Patrick C Hermann; Bruno Sainz
Journal:  Pancreatology       Date:  2016-04-14       Impact factor: 3.996

3.  Constitutive heterochromatin reorganization during somatic cell reprogramming.

Authors:  Eden Fussner; Ugljesa Djuric; Mike Strauss; Akitsu Hotta; Carolina Perez-Iratxeta; Fredrik Lanner; F Jeffrey Dilworth; James Ellis; David P Bazett-Jones
Journal:  EMBO J       Date:  2011-04-05       Impact factor: 11.598

4.  Heterochromatin remodeling in embryonic stem cells proceeds through stochastic de-stabilization of regional steady-states.

Authors:  Anastasia Christogianni; Eleftheria Chatzantonaki; Katerina Soupsana; Ioannis Giannios; Aggeliki Platania; Anastasia S Politou; Spyros Georgatos
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-20       Impact factor: 4.490

Review 5.  Concise Review: Stem Cells in Pancreatic Cancer: From Concept to Translation.

Authors:  Deepak Raj; Alexandra Aicher; Christopher Heeschen
Journal:  Stem Cells       Date:  2015-08-14       Impact factor: 6.277

6.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

7.  Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs.

Authors:  Xiaoyan Ning; Yiqi Du; Qiwen Ben; Ling Huang; Xiaoping He; Yanfang Gong; Jun Gao; Hongyu Wu; Xiaohua Man; Jing Jin; Ming Xu; Zhaoshen Li
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

8.  Persistence of side population cells with high drug efflux capacity in pancreatic cancer.

Authors:  Jing Zhou; Chun-You Wang; Tao Liu; Bin Wu; Feng Zhou; Jiong-Xin Xiong; He-Shui Wu; Jing Tao; Gang Zhao; Ming Yang; Shan-Miao Gou
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

9.  ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.

Authors:  Michael P Kim; Jason B Fleming; Huamin Wang; James L Abbruzzese; Woonyoung Choi; Scott Kopetz; David J McConkey; Douglas B Evans; Gary E Gallick
Journal:  PLoS One       Date:  2011-06-13       Impact factor: 3.240

10.  The Metastatic Potential and Chemoresistance of Human Pancreatic Cancer Stem Cells.

Authors:  Vikash J Bhagwandin; J Michael Bishop; Woodring E Wright; Jerry W Shay
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

View more
  1 in total

1.  Enrichment of Melanoma Stem-Like Cells via Sphere Assays.

Authors:  Nabanita Mukherjee; Karoline A Lambert; David A Norris; Yiqun G Shellman
Journal:  Methods Mol Biol       Date:  2021
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.